On Friday, Goldman Sachs initiated coverage on Alarm.com (NASDAQ:), listing on NASDAQ:ALRM stock, with a Neutral rating and a price target of $64.00....
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute...